Related references
Note: Only part of the references are listed.Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors
Lothar Hambach et al.
BLOOD (2008)
Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer
Anna Woloszynska-Read et al.
CLINICAL CANCER RESEARCH (2008)
Demethylating agents in myeloid malignancies
Guillermo Garcia-Manero
CURRENT OPINION IN ONCOLOGY (2008)
Concordant epigenetic silencing of transforming growth factor-β signaling pathway genes occurs early in breast carcinogenesis
Rebecca A. Hinshelwood et al.
CANCER RESEARCH (2007)
Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations
Eric Spierings et al.
PLOS GENETICS (2007)
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2′-deoxycytidine in cutaneous melanoma:: Immunotherapeutic implications
Ester Fonsatti et al.
CLINICAL CANCER RESEARCH (2007)
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
Hagop Kantarjian et al.
BLOOD (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
A Uniform Genomic Minor Histocompatibility Antigen Typing Methodology and Database Designed to Facilitate Clinical Applications
Eric Spierings et al.
PLOS ONE (2006)
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura
David S. Schrump et al.
CLINICAL CANCER RESEARCH (2006)
The diallelic locus encoding the minor histocompatibility antigen HA-1 is evolutionarily conserved
B Wieles et al.
TISSUE ANTIGENS (2006)
De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model
ZS Guo et al.
CANCER RESEARCH (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Evaluation of a 7-day continuous intravenous infusion of decitabine: Inhibition of promoter-specific and global genomic DNA methylation
WE Samlowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Discovery of epigenetically masked tumor suppressor genes in endometrial cancer
N Takai et al.
MOLECULAR CANCER RESEARCH (2005)
Immunotherapy of cancer through targeting of minor histocompatibility antigens
L Hambach et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
JPJ Issa et al.
BLOOD (2004)
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine
L Sigalotti et al.
CANCER RESEARCH (2004)
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: Toxicity, clinical response, and immunological response to minor histocompatibility antigens
SS Tykodi et al.
CLINICAL CANCER RESEARCH (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Epigenetic targets for immune intervention in human malignancies
M Maio et al.
ONCOGENE (2003)
The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells
CA Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer
M Bregni et al.
BLOOD (2002)
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens
AM Dickinson et al.
NATURE MEDICINE (2002)
Comprehensive analysis of CpG islands in human chromosomes 21 and 22
D Takai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of HLA class I antigens and restoration of antigen-specific ctl response in melanoma cells following 5-aza-2′-deoxycytidine treatment
A Serrano et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Genomic organization of the human cholesterol-responsive ABC transporter ABCA7: Tandem linkage with the minor histocompatibility antigen HA-1 gene
WE Kaminski et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
R Childs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)